top of page
IDENTIMAB
Identimab is a revolutionary Software-as-a-Medical Device platform that combines existing molecular imaging technology with our patented algorithms to quantify patient response to a monoclonal antibody.
A molecular imaging approach to precision medicine
Leveraging AI to bring molecular imaging to the clinic
Application areas
Monoclonal antibody selection
IDENTIMAB guides monoclonal antibody selection to improve patient outcomes
Informing clinical trial design
IDENTIMAB informs clinical trial design through identification of responder populations
Inflammatory phenotyping
IDENTIMAB delivers a step change in inflammatory phenotyping for novel target identification and validation
bottom of page